PHSC 5920 — Clinical Application of Cannabis and Cannabinoids
4 semester hoursGraduateLecture
Focuses on the application of (pre)clinical research results from experimental and human cannabis and cannabinoid research to therapeutics invention. Develops foundational knowledge of the drug-approval process and its oversight/regulatory processes, drug-target identification/validation, the human endocannabinoid system, ECS drug targets for drug-like small molecules, and addresses unsolved medical problems by advancing ECS modulators as potential drug treatments for various diseases. Reviews relevant literature on these topics relating to the medical applications of cannabis and new chemical entities that modulate the ECS. Discusses the design and outcomes of natural and synthetic ECS-targeting agents for indications including overweight/obesity, pain management, and substance-use disorders. Promotes the preparedness for conducting research, consultation and working with healthcare providers and policy makers. External guests are invited to share clinical/industrial insights.